AA
AlphaCentric Advisors’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-330,000
| Closed | -$343K | – | 223 |
|
|
2024
Q3 | $343K | Sell |
330,000
-670,000
| -67% | -$697K | 0.26% | 101 |
|
|
2024
Q2 | $1.73M | Hold |
1,000,000
| – | – | 1.27% | 21 |
|
|
2024
Q1 | $2.39M | Hold |
1,000,000
| – | – | 1.44% | 17 |
|
|
2023
Q4 | $3.33M | Buy |
1,000,000
+87,500
| +10% | +$291K | 2.24% | 8 |
|
|
2023
Q3 | $3.41M | Hold |
912,500
| – | – | 1.94% | 8 |
|
|
2023
Q2 | $3.9M | Buy |
912,500
+558,000
| +157% | +$2.38M | 2.16% | 6 |
|
|
2023
Q1 | $2.42M | Buy |
354,500
+167,000
| +89% | +$1.14M | 1.67% | 12 |
|
|
2022
Q4 | $1.49M | Buy |
187,500
+134,500
| +254% | +$1.07M | 1.47% | 13 |
|
|
2022
Q3 | $509K | Buy |
+53,000
| New | +$509K | 0.52% | 55 |
|
|
2021
Q4 | – | Sell |
-35,000
| Closed | -$562K | – | 230 |
|
|
2021
Q3 | $562K | Sell |
35,000
-16,500
| -32% | -$265K | 0.14% | 63 |
|
|
2021
Q2 | $712K | Buy |
51,500
+40,500
| +368% | +$560K | 0.19% | 41 |
|
|
2021
Q1 | $161K | Buy |
11,000
+9,400
| +588% | +$138K | 0.05% | 113 |
|
|
2020
Q4 | $28K | Hold |
1,600
| – | – | 0.01% | 197 |
|
|
2020
Q3 | $29K | Sell |
1,600
-400
| -20% | -$7.25K | 0.01% | 130 |
|
|
2020
Q2 | $36K | Buy |
+2,000
| New | +$36K | 0.02% | 100 |
|